2012.06.11 Weekly Broadcast Email

The following updates were updates made to the CCCWFU CCOP Research Base website for the week of June 11, 2012.

 

 

General Announcement:

In preparation for the Annual Meeting in October, we would like to request that each site provide input as to the challenges that you face as well as the successful strategies that are utilized when screening and recruiting underserved populations to clinical trials. This information can be sent to Lisa Autry at lautry@wakehealth.edu. We would like to receive this information by Wednesday June 20, 2012.

 


New Study Opens: 97211
We are pleased to announce the opening of a new study,
A Feasibility Study of Donepezil in Female Breast Cancer Survivors with Self-Reported Cognitive Dysfunction Following Chemotherapy. 

The study protocol, consents and appendices can be found on the website:  http://www.wakehealth.edu/cancer/researchBase/Protocols/97211/


99211 Announcement:
(Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Lung Cancer Patients Receiving Outpatient Treatment: A Pilot Study)

 

New Instructions: For all patients assigned to the Quitline arm only: Immediately after faxing the Quit Line for Life Program Enrollment Form to the Quitline staff, email the request below to Mark Campbell, the Quitline contact person who will confirm your patients enrollment and ensure that your patient receives a phone call from the Quitline staff.

 

To Mark Campbell [Mark.Campbell@alere.com],

 

Study Participant # (insert PID only) has completed the Quit Line for Life Program Enrollment Form for Wake Forest Study 99211: “Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Lung Cancer Patients Receiving Outpatient Treatment: A Pilot Study.” This form was faxed to the Quitline staff on (insert date form was faxed).  

 

If you did not receive this faxed participant enrollment form or if you have questions, please contact me as soon as possible.

 

Thank you,

(insert your name)

 


97202:  Randomized Double-Blind Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Cancer Treatment Related Fatigue in Breast Cancer Patients
This study was closed in 2009 and has recently been terminated.  Please see the website, for publications.

Quick Reference

Research Base

Fax 336-716-6275
Phone 336-716-0891

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 06-18-2012
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.